Relmada Therapeutics has a total of 72 patents globally, out of which 25 have been granted. Of these 72 patents, more than 34% patents are active. The United States of America is where Relmada Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Relmada Therapeutics.
Relmada Therapeutics was founded in 2004. Relmada Therapeutics is a biotech firm that works on conditions affecting the brain and spinal cord, specifically focusing on treating major depressive disorder.
Do read about some of the most popular patents of Relmada Therapeutics which have been covered by us in this article and also you can find Relmada Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Relmada Therapeutics patent portfolio.
How many patents does Relmada Therapeutics have?
Relmada Therapeutics has a total of 72 patents globally. These patents belong to 17 unique patent families. Out of 72 patents, 25 patents are active.
How Many Patents did Relmada Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Relmada Therapeutics Applications Filed | Relmada Therapeutics Patents Granted |
| 2023 | – | 1 |
| 2022 | – | 1 |
| 2021 | – | 1 |
| 2020 | 2 | 5 |
| 2019 | 1 | 6 |
| 2018 | 1 | 3 |
| 2017 | 5 | 1 |
| 2016 | 3 | 5 |
| 2015 | 1 | 1 |
| 2012 | 1 | 1 |
How many Relmada Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Relmada Therapeutics File in Different Countries?
Countries in which Relmada Therapeutics Filed Patents
| Country | Patent |
| United States of America | 15 |
| Europe (EPO) | 8 |
| China | 4 |
| Korea (South) | 3 |
| Germany | 3 |
| Austria | 3 |
| Canada | 3 |
| Hong Kong (S.A.R.) | 3 |
| Mexico | 2 |
| Australia | 2 |
| Singapore | 2 |
| Japan | 2 |
| India | 2 |
| Denmark | 2 |
| Israel | 1 |
Where are Research Centers of Relmada Therapeutics Patents Located?
10 Best Relmada Therapeutics Patents
WO2008024408A2 is the most popular patent in the Relmada Therapeutics portfolio. It has received 147 citations so far from companies like Axim Biotechnologies, 4P Therapeutics, KannaInnovations.
Below is the list of 10 most cited patents of Relmada Therapeutics:
| Publication Number | Citation Count |
| WO2008024408A2 | 147 |
| WO2008024490A2 | 135 |
| US20090082466A1 | 101 |
| US20120065221A1 | 91 |
| WO2007087452A2 | 56 |
| WO2008033351A2 | 53 |
| US20120178771A1 | 41 |
| US20040209850A1 | 38 |
| WO2008134071A1 | 36 |
| WO2008115572A1 | 32 |
What are Relmada Therapeutics key innovation segments?
What Technologies are Covered by Relmada Therapeutics?
The chart below distributes patents filed by Relmada Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Relmada Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Relmada Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!